New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

PAXLOVID (nirmatrelvir tablets; ritonavir tablets)

This specialty medication is authorized and manufactured internationally and is not registered or commercially distributed for retail sale in India. To verify patient eligibility, check international supply availability, or understand the regulatory logistics and documentation process: Call our Compliance Desk at 9891296838 or Email your Inquiry query@southdelhipharma.com.

Paxlovid (nirmatrelvir co-packaged with ritonavir) is an oral antiviral medication used to treat mild-to-moderate COVID-19 in adults and adolescents (aged 12 and older, weighing at least 88 pounds/40 kg) who are at high risk for progressing to severe illness, hospitalization.

Brand Name: PAXLOVID – On Request
Generic Name: nirmatrelvir tablets; ritonavir tablets
Strength: • Tablets: nirmatrelvir 150 mg
• Tablets: ritonavir 100 mg
Manufacturer: Pfizer Inc.
Approved By: EMA, USFDA
Get access to medicines: In India
Price: On Request

See full prescribing information for PAXLOVID: Patient Information

Is PAXLOVID (nirmatrelvir tablets; ritonavir tablets) officially available/approved in India?

No, as of now, PAXLOVID (nirmatrelvir tablets; ritonavir tablets) is not officially marketed or registered for sale in India. It is mainly accessed in India through a Named Patient Program (NPP), which allows for the legal importation of the medication for patients with a valid prescription from the Registered Medical Practitioner (RMP). For sourcing facilitation services contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or  you can Call/WhatsApp at 9891296838.

Category
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

South Delhi Pharma is dedicated to facilitating access to critical, globally approved pharmaceutical therapies tailored to individual patient needs. Established in 1996, It has built a trusted reputation for assisting patients and healthcare institutions in navigating the regulatory frameworks required to securely source high-quality, international life-saving medications.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

This is an inquiry and facilitation request form. Submission does not constitute a sale, purchase order, or guarantee of medicine availability.

Description

Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID-19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor, slowing down nirmatrelvir metabolism and therefore boosting its effect.

PAXLOVID (nirmatrelvir tablets; ritonavir tablets), co-packaged for oral use Initial U.S. Approval: 2023

Get Assistance for PAXLOVID Import

Need urgent access to PAXLOVID? We’re here to help.

  • Expert support for documentation & approvals
  • Fast-track import coordination
  • End-to-end patient assistance

Call Now | Enquire Today | WhatsApp Support Available

Contact Sourcing Facilitation Team

Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com

NEWS / UPDATES

Get Access To PAXLOVID (nirmatrelvir tablets; ritonavir tablets) In India

In India, access is facilitated through a legally compliant Named Patient Program (NPP), as per guidelines from the Central Drugs Standard Control Organization. This ensures safe and regulated import of the medicine for individual patients. Brand Name “PAXLOVID” or Generic Name “nirmatrelvir tablets; ritonavir tablets” can be imported for personal use under “Named Patient Program” treatment in in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla India.. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.

Note: South Delhi Pharma, act as a facilitation partner and do not manufacture, sell, or distribute pharmaceutical products. All facilitation activities are conducted in accordance with applicable Indian pharmaceutical and trade regulations. 

Related Products